Target Medicals Group Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 5

Target Medicals Group General Information

Description

Developer of therapeutic drugs designed to treat a range of medical conditions. The company's platform offers aldosterone synthase inhibitors and drug development programs targeting infectious diseases, enabling healthcare providers and researchers to treat hormone-related conditions and drug-resistant infections.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Mysliborska 85
  • Warsaw, 05-077
  • Poland
+48 736
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Mysliborska 85
  • Warsaw, 05-077
  • Poland
+48 736

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Target Medicals Group Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) 29-Dec-2025 Completed Pre-Clinical Trials
3. Later Stage VC (Series 1) 01-Feb-2022 Completed Pre-Clinical Trials
2. Seed Round 09-Oct-2017 $190K $190K Completed Pre-Clinical Trials
1. Grant 01-Jan-2016 $86.8K Completed Startup
To view Target Medicals Group’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Target Medicals Group Patents

Target Medicals Group Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026197933-A1 Compounds having antimycobacterial activity Pending 18-Mar-2025
WO-2019190354-A1 Phenylformamidine derivatives having antimycobacterial activity Inactive 29-Mar-2018

Target Medicals Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Target Medicals Group Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
AstraZeneca Corporation Minority
Russian Direct Investment Fund Sovereign Wealth Fund Minority
Unicorn Capital Partners Venture Capital Minority
Skolkovo Foundation Limited Partner
Startup Village Government
To view Target Medicals Group’s complete investors history, request access »

Target Medicals Group FAQs

  • When was Target Medicals Group founded?

    Target Medicals Group was founded in 2015.

  • Where is Target Medicals Group headquartered?

    Target Medicals Group is headquartered in Warsaw, Poland.

  • What is the size of Target Medicals Group?

    Target Medicals Group has 7 total employees.

  • What industry is Target Medicals Group in?

    Target Medicals Group’s primary industry is Drug Discovery.

  • Is Target Medicals Group a private or public company?

    Target Medicals Group is a Private company.

  • What is Target Medicals Group’s current revenue?

    The current revenue for Target Medicals Group is .

  • How much funding has Target Medicals Group raised over time?

    Target Medicals Group has raised $190K.

  • Who are Target Medicals Group’s investors?

    AstraZeneca, Russian Direct Investment Fund, Unicorn Capital Partners, Skolkovo Foundation, and Startup Village have invested in Target Medicals Group.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process